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Localization of a Gene (CORD7) for a Dominant
Cone-Rod Dystrophy to Chromosome 6q
To the Editor:
The cone-rod dystrophies are a heterogeneous group of
retinal disorders, often leading to registrable blindness,
that are characterized by an initial loss of cone photo-
receptors, followed by the degeneration of rod photo-
receptors. Recent genetic studies have mapped the dis-
order to a number of different chromosomal locations
(Evans et al. 1994; Kelsell et al. 1997), although, to date,
mutations have been identified in only three genes, per-
ipherin/RDS (Nakazawa et al. 1994, 1996a, 1996b;
Kohl et al. 1997), CRX (Freund et al. 1997), and retinal
guanylate cyclase (Kelsell et al., in press). In the present
study, a new chromosomal localization for an autosomal
dominant cone-rod dystrophy is reported. In accordance
with the guidelines of the Nomenclature Review Com-
mittee, “CORD7” has been assigned as the gene des-
ignation for this disorder.
A four-generation British family was recruited for the
study. Affected members of the family first became aware
of reduced color vision and visual acuity between the
ages of 20 and 40 years. As the disorder progressed, they
reported difficulty seeing in bright light, and one indi-
vidual (IV-1; fig. 1A) reported visual problems in dim
light. At the onset of symptoms, retinal pigmentary
changes were already present around the fovea, simu-
lating a bull’s eye dystrophy, which developed to mac-
ular atrophy. Electrophysiological tests in advanced dis-
ease showed that scotopic rod responses were barely
detectable and that all cone responses were severely at-
tenuated (fig. 1B) but with no change in implicit time.
Pattern electroretinography (ERG) was extinguished, in
keeping with the severe macular dysfunction. No sig-
nificant intraocular asymmetry was present.
EDTA blood samples were obtained from eight af-
fected family members, eight unaffected family mem-
bers, and four spouses, for linkage analysis (fig. 1). DNA
was extracted from these samples with a Nucleon II ex-
traction kit (Scotlab Bioscience). Genotyping was per-
formed with microsatellite-marker loci, as described
elsewhere (Kelsell et al. 1995). In brief, 100 ng DNA
samples were PCR amplified and labeled by a[32P]-dCTP
incorporation. These amplified products then were sep-
arated by denaturing PAGE and were visualized by
autoradiography.
Data were collected with LINKSYS 3.1 (Attwood and
Bryant 1988), and two-point linkage analysis was per-
formed with the MLINK subprogram of LINKAGE
package 5.10 (Lathrop et al. 1984). Allele frequencies
were calculated from the four spouses in this family as
well as from an additional 10 normal individuals taken
from four other British families. The cone-rod dystrophy
phenotype in this family was analyzed as an autosomal
dominant trait with complete penetrance and a fre-
quency of .001 for the affected allele.
Since a variety of retinal degenerations have been
mapped to chromosome 6 (Nichols et al. 1993; Small
et al. 1993; Weleber et al. 1993; Wells et al. 1993; Nak-
azawa et al. 1994; Stone et al. 1994; Kelsell et al. 1995;
Reig et al. 1995; Kohl et al. 1997), we chose this region
of the genome as the first candidate area for linkage
analysis. Two-point linkage data for the family studied
(data not shown) excluded the 6p12 region occupied by
peripherin/RDS and the 6q14-q16.2 region occupied by
the genes for North Carolina macular dystrophy
(MCDR1; Small et al. 1993) and progressive bifocal cho-
rioretinal atrophy (PBCRA; Kelsell et al. 1995). Signif-
icant linkage was obtained at the Stargardt-like domi-
nant progressive macular dystrophy region on chro-
mosome 6q13-q15 (Stone et al. 1994). Two-point LOD
scores obtained after genotyping 16 microsatellite-
marker loci are shown in figure 2. Significant linkage
was obtained at two of these marker loci, with a max-
imum LOD score of 3.61 (recombination fraction of
0.00) at D6S1681. The haplotypes that define the most
likely chromosomal interval for the disease-causing gene
are indicated in figure 2. Affected individual III-3 is re-
combinant at D6S430 (as well as at the more centro-
meric marker locus D6S257), placing the disease gene
telomeric to D6S430. Affected individual II-2 is recom-
binant for D6S1625 (as well as the more telomeric
marker locus D6S252), placing the disease gene cen-
tromeric to D6S1625. Three of the marker loci
(D6S1619, D6S1681, and D6S456) that give maximum
LOD scores at zero recombination were completely in-
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Figure 1 A, CORD7 pedigree and haplotype results for 16 microsatellite-marker loci situated on chromosome 6q. The identities of
microsatellite markers are shown to the left of individual IV-1. The haplotype that appears to be segregating with the disease in this family is
boxed. The bottom entry in the list represents the C and G alleles of the IMPG1 gene. The brackets indicate inferred haplotypes, for individuals
I-1 and I-2. B, ERG traces from patient II-6 and from a normal control. Except for the pattern ERG (“PERG”), note that different axis scales
are used for patient and control traces.
formative in these recombinant individuals. Therefore,
the disease-causing gene in this family has been localized
between D6S430 and D6S1625, a region estimated to
be 7 cM in size (Dib et al. 1996).
IMPG1 is an interphotoreceptor matrix proteoglycan
gene that has been localized to chromosome 16q14.2-
q15 (Felbor et al., in press). It therefore is a good func-
tional candidate for retinal dystrophies mapping to this
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region of the genome (see Gehrig et al., in press). Exon
13 contains a frequent C/G polymorphism (Gehrig et
al., in press) that enabled us to follow the segregation
of the IMPG1 gene in our CORD7 family. The exon
was amplified by use of primers and reaction conditions,
as described elsewhere (Gehrig et al., in press); sequenc-
ing was performed with the PCR-amplification primers
by use of AmpliTaq FS polymerase cycle sequencingwith
dye-labeled dideoxyterminators, and the products were
visualized on an Applied Biosystems model 373 se-
quencer. In figure 1, the C and G alleles are indicated
as 1 and 2, respectively. The presence of a crossover in
affected individual II-2 places the IMPG1 gene telomeric
to CORD7 and excludes it as the disease gene.
An autosomal dominant Stargardt-like disease
(STGD3) (Stone et al. 1994) also maps to this region of
chromosome 6. Clinically, this disorder is quite distinct
from CORD7; it is described as a childhood-onset ma-
culopathy with white/yellow flecks in the midperipheral
retina. In contrast, the CORD7 disease is of middle-age
onset, and no flecks are present in the macula or pe-
ripheral retina of affected individuals. However, the pos-
sibility that different mutations in the same gene are
responsible for STGD3 and CORD7 cannot be ruled
out, since clinical heterogeneity is not an infrequent find-
ing. For example, different mutations in the peripherin/
RDS gene result in retinitis pigmentosa, macular dys-
trophy, cone-rod dystrophy, pattern dystrophy, or cen-
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Figure 2 Macular dystrophies mapping to human chromosome 6. The table to the right shows the two-point LOD scores for linkage
between CORD7 and marker loci situated on chromosome 6q. The 7-cM region to which CORD7 maps and the previous 18-cM localization
for STDG3 are depicted schematically to the left of the table. The approximate positions of the other macular dystrophy genes mapping to
chromosome 6, with their flanking marker loci, also are shown (not to scale). The peripherin/RDS gene maps to the short arm of chromosome
6, and the regions for MCDR1 and PBCRA map below the STDG3 locus.
tral areolar choroidal dystrophy (Nichols et al. 1993;
Weleber et al. 1993; Wells et al. 1993; Nakazawa et al.
1994; Reig et al. 1995; Kohl et al. 1997), and a similar
situation is seen for the ABCR gene, in which different
mutations cause either recessive Stargardt macular de-
generation (Allikmets et al. 1997) or recessive retinitis
pigmentosa (Martinez-Mir et al. 1998).
Two other retinal dystrophies principally affecting the
posterior pole of the eye have been mapped just telo-
meric to STGD3 (Small et al. 1993; Kelsell et al. 1995;
also see fig. 2), and cytogenetic alterations affecting the
chromosome 6q region have been associated with a va-
riety of other retinal diseases (Milosevic and Kalicanin
1975; Hagemeijer et al. 1977; Pierpont et al. 1986; Tra-
nebjaerg et al. 1986). This has led to the suggestion that
there may be a family of retinal genes located on chro-
mosome 6q (Small et al. 1992; Kelsell et al. 1995).
The mapping of CORD7 in this study adds to the
expanding list of localizations for cone-rod dystrophies.
Clearly, more family studies are required to determine
the quantitative importance of each locus. The cloning
of the disease genes should aid in our understanding of
the etiology of this diverse set of degenerative disorders.
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